Baxter's goal is to continue expanding its already
strong position in the oncology market worldwide with the
aim of becoming the partner of reference for patients, health
professionals and customers.
Today, Baxter offers a wide range of pharmaceutical
products, delivery systems and services for the treatment
of patients suffering from cancer as a life-threatening condition
with the aim to improve the efficacy and safety of the treatment
as well as the patients' quality of life.
Our Oncology franchise bases its product sources on both in-house
development of value-added product innovation and the in-licensing
of competitive products. Baxter seeks strategic collaborations
with companies working in the development of products (in
both pre-clinical and clinical phases) or in registration
International companies in the field of oncology looking for
a strong partner can benefit from marketing through Baxter
as a global player.